Stem Point Capital LP Ocular Therapeutix, Inc Transaction History
Stem Point Capital LP
- $314 Billion
- Q1 2025
A detailed history of Stem Point Capital LP transactions in Ocular Therapeutix, Inc stock. As of the latest transaction made, Stem Point Capital LP holds 124,523 shares of OCUL stock, worth $885,358. This represents 0.29% of its overall portfolio holdings.
Number of Shares
124,523Holding current value
$885,358% of portfolio
0.29%Shares
2 transactions
Others Institutions Holding OCUL
# of Institutions
207Shares Held
135MCall Options Held
426KPut Options Held
119K-
Deep Track Capital, LP Greenwich, CT14.3MShares$102 Million3.66% of portfolio
-
Summer Road LLC West Palm Beach, FL13.9MShares$98.7 Million98.53% of portfolio
-
Vr Adviser, LLC New York, NY12.8MShares$90.7 Million22.59% of portfolio
-
Black Rock Inc. New York, NY11.5MShares$81.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.36MShares$59.5 Million0.0% of portfolio
About OCULAR THERAPEUTIX, INC
- Ticker OCUL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,966,896
- Market Cap $547M
- Description
- Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...